ITEOS THERAPEUTICS INC (ITOS)
US46565G1040 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 19.90M | |||
| Cash Equivalents | 251.18M | 284.80M | 848.50M | 336.30M | N/A | |||
| Marketable Securities | 280.74M | 328.40M | N/A | N/A | N/A | |||
| Receivables | 6.50M | 2.40M | 12.10M | 300.00K | 5.30M | |||
| Other Current Assets | 12.24M | 12.70M | 14.10M | 2.90M | 900.00K | |||
| Total Current Assets | 550.65M | 628.30M | 874.70M | 339.50M | 26.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.73M | 6.80M | 7.40M | 1.40M | 1.30M | |||
| Investments And Advances | 100.54M | 118.20M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 1.16M | 600.00K | 600.00K | 400.00K | 400.00K | |||
| Total Non-Current Assets | 116.94M | 126.70M | 10.00M | 5.10M | 4.60M | |||
| TOTAL ASSETS | 667.59M | 755.00M | 884.70M | 344.60M | 30.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 16.87M | 20.60M | 17.90M | 7.50M | 4.30M | |||
| Accounts Payable | 11.29M | 7.70M | 5.10M | 3.00M | 1.20M | |||
| Other Current Liabilities | 11.85M | 13.80M | 281.10M | 4.50M | 7.80M | |||
| Total Current Liabilities | 40.01M | 42.00M | 304.10M | 15.00M | 13.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 52.35M | 49.70M | 27.80M | 6.40M | 1.90M | |||
| Total Non-Current Liabilities | 52.35M | 49.70M | 27.80M | 6.40M | 1.90M | |||
| TOTAL LIABILITIES | 92.36M | 91.70M | 331.90M | 21.40M | 15.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 124.63M | 237.30M | 140.60M | -73.90M | -35.90M | |||
| Additional Paid In Capital | 463.80M | 435.70M | 413.20M | 396.40M | 0.00 | |||
| Common Shares | 36.00K | 0.00 | 0.00 | 0.00 | 51.80M | |||
| Other Shareholders' Equity | -13.24M | -9.60M | -1.00M | 600.00K | -200.00K | |||
| Shares Outstanding | 35.84M | 35.70M | 35.50M | 35.00M | 33.30M | |||
| Tangible Book Value per Share | 16.05 | 18.58 | 15.57 | 9.23 | -1.08 | |||
| Total Shareholders' Equity | 575.23M | 663.30M | 552.80M | 323.20M | 15.70M | |||
| TOTAL LIABILITIES AND EQUITY | 667.59M | 755.00M | 884.70M | 344.60M | 30.70M | |||
| Statistics | ||||||||
| Current Ratio | 13.76 | 14.96 | 2.88 | 22.63 | 1.98 | |||
| Return On Assets (ROA) | -16.87% | 12.81% | 24.25% | -12.59% | -86.32% | |||
| Return On Equity (ROE) | -19.58% | 14.58% | 38.80% | -13.43% | -168.79% | |||
| Return On Invested Capital (ROIC) | N/A | 13.99% | 33.32% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 99.98% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | 99.98% | N/A | N/A | N/A | |||
All data in USD